VIVACELLE BIO
Live / Registered — Registered — Section 8 accepted (as of 23 Dec 2025)
What this means for you
Registered since 04 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87232402
- Registration number
- 6119221
- Mark type
- Design + words
- Filed
- 10 Nov 2016
- Published for opposition
- 15 May 2018
- Registered
- 04 Aug 2020
- Attorney of record
- Michael Ye
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical for treating hypovolemia and lack of blood supply, veterinary preparations for treating hypovolemia and lack of blood supply
Owner
- Vivacelle Bio, Inc., Shreveport, LA, US
- Vivacelle Bio, Inc., Shreveport, LA, US
- Vivacelle Bio, Inc., Shreveport, LA, US
Prosecution history
- 23 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 23 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 22 Dec 2025 — TEAS SECTION 8 RECEIVED
- 19 Dec 2025 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 19 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 04 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 02 Jul 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Jul 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jun 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jun 2020 — USE AMENDMENT FILED
- 26 Jun 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jun 2020 — TEAS STATEMENT OF USE RECEIVED
- 10 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED